Unconventional Ventures

Unconventional Ventures is a venture capital firm located in Copenhagen, Denmark, founded in 2019. It specializes in early-stage investments, specifically in scalable tech startups at the pre-seed and seed stages. The firm focuses on supporting underrepresented founders, including women, LGBTQ individuals, people of color, and immigrants, believing that these groups represent significant market opportunities. Unconventional Ventures primarily targets investments in the Nordic countries and seeks to create a positive impact through its portfolio companies by addressing global market needs.

Vera Baker

Venture Partner

Nora Bavey

General Partner

Alexis Horowitz-Burdick

Venture Partner

Thea Messel

Founder, General Partner

9 past transactions

The Blue Box Biomedical Solutions

Seed Round in 2024
Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Meela

Seed Round in 2024
Meela AB is a mental health service provider that specializes in connecting women with psychologists and psychotherapists through a user-friendly platform. By utilizing a matching algorithm, Meela effectively pairs individuals with therapists based on their specific profiles and needs, ensuring a personalized therapy experience. The service offers both online and in-person therapy sessions and is designed to assist individuals dealing with mild to moderate mental health issues. Meela prioritizes enhancing the therapeutic alliance and aims to reduce the likelihood of premature termination of therapy, making it a valuable resource for women seeking mental health support in Sweden.

Climate X

Series A in 2024
Climate X is a global climate physical risk data analytics company that specializes in climate risk management services. The firm provides tools to project and predict the impacts of climate change and extreme weather events by integrating climate models with current real-world data. Through its physical modeling capabilities, Climate X enables businesses and governments to anticipate regulatory requirements and adapt to evolving climate-related challenges. Its clientele includes prominent financial institutions in sectors such as banking, real estate, and insurance, highlighting its relevance in a rapidly changing climate landscape.

Cellugy

Seed Round in 2024
Cellugy is a biotechnology company developing cellulose-based materials to replace single-use plastics. It uses a fermentation platform that converts renewable resources into natural bio-cellulose, delivering cellulose with quality comparable to natural sources while offering competitive economics and a smaller environmental footprint. By substituting petrochemicals in products with this bio-cellulose, the company aims to maintain production momentum and performance. The technology enables the production of different grades and qualities of cellulose, enabling applications across multiple industries, including personal care, packaging, textiles, and food. The company focuses on providing sustainable alternatives and reducing reliance on fossil-based plastics, positioning itself at the intersection of materials science and circular economy.

Moonhub

Venture Round in 2024
Moonhub is a London-based company that specializes in virtual reality training solutions for organizations. Established in 2016, it offers an immersive platform that allows employees to engage in interactive role-play scenarios, enhancing their learning and retention of knowledge. The use of advanced, remotely deployable technology coupled with a patented data capture system distinguishes Moonhub's approach, enabling businesses to optimize their training processes and unlock the full potential of their workforce.

Octarine Bio

Series A in 2023
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.

Alba Health

Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.